Zhengyin Liu
Overview
Explore the profile of Zhengyin Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
3175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jiang J, Wang L, Hu Y, Chen X, Li P, Zhang J, et al.
EBioMedicine
. 2025 Mar;
113:105627.
PMID: 40024096
Background: Carbapenem-resistant hypervirulent Klebsiella pneumoniae (CR-hvKp) has been increasingly reported worldwide, posing a severe challenge to public health; however, the mechanisms driving its emergence and global dissemination remain unclear. Methods:...
2.
Jiang J, Komarow L, Hill C, Boutzoukas A, Hanson B, Arias C, et al.
J Infect Dis
. 2024 Dec;
PMID: 39667036
Background: Despite the global public health threat posed by carbapenem-resistant Enterobacter spp., clinical and molecular epidemiological studies on international isolates remain scarce. Historically, the taxonomy of Enterobacter has been challenging,...
3.
Tian X, Lin J, Zhou M, Ge Y, Li T, Zhang L, et al.
Infect Drug Resist
. 2024 Oct;
17:4403-4415.
PMID: 39421018
Purpose: To evaluate the clinical outcomes and safety of tigecycline (TGC) plus cefoperazone/sulbactam (CPS) or TGC monotherapy in patients with hospital-acquired pneumonia (HAP) caused by Carbapenem-Resistant (CRAB). Methods: This was...
4.
Luo L, Li X, Song X, Lyu W, Liu Z, Wang H, et al.
Chin Med J (Engl)
. 2024 Sep;
137(19):2375-2377.
PMID: 39245636
No abstract available.
5.
Zhang L, Zhou M, Wang Z, Zhu H, Lin J, Lu M, et al.
Infect Drug Resist
. 2024 Jun;
17:2379-2387.
PMID: 38894887
Background: In China, due to the large population, infections caused by Nocardia may not be as rare. Unfortunately, there is still inadequate knowledge of the clinical impact caused by Nocardia....
6.
Li Q, Li J, Zhou M, Ge Y, Liu Z, Li T, et al.
Front Immunol
. 2024 May;
15:1354349.
PMID: 38707895
Antiphospholipid antibodies (aPL) are both laboratory evidence and causative factors for a broad spectrum of clinical manifestations of antiphospholipid syndrome (APS), with thrombotic and obstetric events being the most prevalent....
7.
Liu X, Xing H, Lin J, Sun J, Wang Y, Liu Y, et al.
Infect Drug Resist
. 2024 Feb;
17:709-718.
PMID: 38410795
Background: is prevalent in South Asia. Latent infection of travellers make the diagnosis difficult. There are similarities in clinical manifestations between infection and lymphoma. Brain abscess is a rare form...
8.
Wang M, Ge L, Chen L, Komarow L, Hanson B, Reyes J, et al.
Clin Infect Dis
. 2023 Sep;
78(2):248-258.
PMID: 37738153
Background: Carbapenem-resistant Acinetobacter baumannii (CRAb) is 1 of the most problematic antimicrobial-resistant bacteria. We sought to elucidate the international epidemiology and clinical impact of CRAb. Methods: In a prospective observational...
9.
Lin J, Zhang L, Zhou M, Tian X, Chen J, Lu M, et al.
Infect Dis Ther
. 2023 Aug;
12(8):2165-2177.
PMID: 37653121
Introduction: This study aimed to evaluate the different efficacies between monotherapy and combination therapy with ceftazidime/avibactam (CAZ/AVI) in treating carbapenem-resistant Klebsiella pneumoniae (CRKP) infection. Methods: We retrospectively analyzed observational multicenter...
10.
Zhang L, Zhou M, Lv W, Li T, Xu Y, Liu Z
J Microbiol Immunol Infect
. 2023 Jul;
56(6):1284-1287.
PMID: 37524645
Helicobacter cinaedi is known to cause various infections in immunocompromised hosts ranging from skin lesions to disseminated septicemia. Identification of H. cinaedi is difficult through conventional identification methods due to...